Quince Therapeutics (QNCX) EPS (Diluted) (2021 - 2026)
Quince Therapeutics (QNCX) EPS (Diluted) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | 1.19 |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | 0.15 |
| 10 | Quince Therapeutics | 200.91 Mn | 200.91 Mn | - | -12.31 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.37 |
| Dec 31, 2025 | -76.98 |
| Sep 30, 2025 | -49.83 |
| Jun 30, 2025 | -68.75 |
| Mar 31, 2025 | -68.41 |
| Dec 31, 2024 | -57.59 |
| Sep 30, 2024 | -25.45 |
| Jun 30, 2024 | -128.68 |
| Mar 31, 2024 | -51.84 |
| Dec 31, 2023 | -47.77 |
| Sep 30, 2023 | -29.67 |
| Jun 30, 2023 | -27.21 |
| Mar 31, 2023 | -68.35 |
| Dec 31, 2022 | -33.04 |
| Sep 30, 2022 | -44.48 |
| Jun 30, 2022 | -102.04 |
| Mar 31, 2022 | -143.63 |
| Dec 31, 2021 | 447.84 |
| Sep 30, 2021 | -145.84 |
| Jun 30, 2021 | -147.05 |